Discover our company

IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery, and aesthetics.

Feel the difference with HTL inside !
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.

At HTL Biotechnology, our mission is to unleash the potential of Hyaluronic Acid and biopolymers.

For over 30 years, our teams have been developing and perfecting a pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide in therapeutic areas such as Ophthalmology, Rheumatology, Dermatology and Medical Aesthetics.

The biggest international pharma industry event is back in Barcelona.The HTL team was present to welcome people and discuss our products and values, also our latest advancements with biopolymers for medical applications.

HTL Biotechnology's new corporate social responsibility strategy will focus on accelerating the company’s commitment to its environment, local ecosystem and employees. 

HTL Biotechnology's engagements have been awarded an Ecovadis gold medal in 2023 and are certified by ISO 14001:2015.